Newman Dignan & Sheerar Inc’s Express Scripts Holding Company ESRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-2,919
Closed -$280K 154
2018
Q3
$280K Sell
2,919
-290
-9% -$24.7K 0.12% 128
2018
Q2
$248 Hold
3,209
0.02% 141
2018
Q1
$230K Sell
3,209
-200
-6% -$15.3K 0.12% 147
2017
Q4
$254K Hold
3,409
0.13% 152
2017
Q3
$216K Hold
3,409
0.12% 151
2017
Q2
$218K Hold
3,409
0.12% 146
2017
Q1
$225 Hold
3,409
0.1% 141
2016
Q4
$235K Hold
3,409
0.14% 130
2016
Q3
$240K Hold
3,409
0.15% 135
2016
Q2
$258K Hold
3,409
0.16% 132
2016
Q1
$234K Buy
3,409
+150
+5% +$10.8K 0.17% 124
2015
Q4
$285K Buy
3,259
+285
+10% +$24.4K 0.2% 115
2015
Q3
$241K Hold
2,974
0.15% 119
2015
Q2
$265K Sell
2,974
-45
-1% -$3.93K 0.19% 124
2015
Q1
$262K Hold
3,019
0.19% 122
2014
Q4
$256 Hold
3,019
0.15% 127
2014
Q3
$213K Hold
3,019
0.16% 136
2014
Q2
$209 Hold
3,019
0.12% 140
2014
Q1
$227K Hold
3,019
0.16% 134
2013
Q4
$212 Buy
+3,019
New +$197K 0.01% 138

Other funds holding ESRX

Newman Dignan & Sheerar Inc's ESRX Position: Q4 2018 in Review

Newman Dignan & Sheerar Inc sold out of Express Scripts Holding Company (ESRX) in Q4 2018, closing a stake of 2,919 shares — an estimated $280K sold.

Newman Dignan & Sheerar Inc first reported a position in ESRX in Q4 2013 and held it in 20 quarters. The position peaked at $285K in Q4 2015. 16 funds tracked by Wall St. Rank hold ESRX as of Q4 2018.

  • Newman Dignan & Sheerar Inc reported no remaining Express Scripts Holding Company position as of Q4 2018 after selling out during the quarter.
  • Newman Dignan & Sheerar Inc sold 2,919 Express Scripts Holding Company shares in Q4 2018, an estimated $280K.
  • Newman Dignan & Sheerar Inc first reported a position in Express Scripts Holding Company in Q4 2013 and held it in 20 quarters.
  • Newman Dignan & Sheerar Inc's Express Scripts Holding Company position peaked at $285K in Q4 2015.
  • 16 funds tracked by Wall St. Rank held Express Scripts Holding Company as of Q4 2018.

Based on Newman Dignan & Sheerar Inc's 13F filing for Q4 2018, filed 24 Jan 2019.